We are live on
!
Find out more
PGP
Prescott General Partners Portfolio holdings
AUM
$1.96B
1-Year Est. Return
58.65%
This Fund
S&P 500
This Quarter
Est. Return
-10.59%
1 Year Est. Return
+58.65%
3 Year Est. Return
+76.84%
5 Year Est. Return
+44.3%
10 Year Est. Return
+728.25%
AUM
$1.27B
AUM Growth
-$183M
(-13%)
Cap. Flow
-$1.37M
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sana Biotechnology
SANA
|
+$785K |
| 2 |
Altimmune
ALT
|
+$585K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 71.64% |
| 2 | Industrials | 10.21% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Communication Services | 7.75% |
| 5 | Healthcare | 0.63% |
Similar funds
GF
MAM
BFG
SP
SLF
GIP
FFS
CAM
Prescott General Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Prescott General Partners held 12 positions worth $1.27B, down 13% from $1.46B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Prescott General Partners's Q3 2022 filing shows 2 closed positions. The largest sale was Sana Biotechnology, an estimated $785K.
By sector, the portfolio is most concentrated in Financials at 72% of assets, up from 69% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Prescott General Partners fully exited Sana Biotechnology in Q3 2022, selling an estimated $785K.
- Prescott General Partners's ten largest holdings make up 100% of its $1.27B portfolio in Q3 2022.
- Prescott General Partners opened 0 new positions and closed 2 in Q3 2022.
- Prescott General Partners's portfolio value fell 13% quarter-over-quarter to $1.27B.
Based on Prescott General Partners's 13F filing for Q3 2022, filed 14 Nov 2022.